Dr. DiLazzaro manages European clinical trials projects with the support of offices and resources in Germany, France, Austria, Italy, UK, Spain, and Sweden. She leads launch and implementation of clinical research projects interfacing with sponsors with hands on all aspects of the clinical research process.

Dr.DiLazzaro brings experience in dealing with several EMEA regulatory and approval projects. She had experience in management of all promotional activities, market analysis, and managed market research programs necessary to aid the development of brand communication strategies. Dr. DiLazzaro has attended many training programs held by prestigious international pharmaceutical companies, worked in development, marketing or sales management for more than ten years. In additional to her medical education, she completed her MBA, marketing specialization, in 2006, through the Academy of Economic studies from the Romanian-Canadian MBA program. Dr. DiLazzaro is fluent in the five major languages spoken in Europe.

Dr. Piticas manages Central and Eastern Europe projects from an MPR office in Bucharest, Romania supported by several offices in Russia, Poland, Bulgaria, Slovakia, and several other operational teams almost in every country in Easter and Central Europe.

Dr. Piticas graduated from Targu Mures Medical and Pharmaceutical University. He completed his MBA in 2006 through the Academy of Economic studies from the Romanian-Canadian MBA program specializing in marketing. Dr. Piticas has worked for large global pharmaceutical companies including GSK. He brings to MPR extensive experience in managing bio-pharmaceutical products development. He has a strong understanding of the regulatory environment of Central and Easter European health markets.

Dr. Steinacher leads clinical studies in South America from feasibility to launch. She manages the registration, approval and implementation of clinical studies in coordination with MPR-Brazil and MPR-Chili. With the Company presence in Cordoba, a medical research hub in South America, and close to several metropolitan cities, and with the support of excellent and experienced teams on all aspects of clinical research, Dr. Steinacher would successfully lead a full service clinical trial project for Sponsors whether as an independent South American study or as part of an international clinical trial project. 

Dr. Steinacher brings to MPR more than 10 years in clinical research experience that covered all aspects of clinical research. Dr. Steinacher supported several clinical studies as an investigator or a sub-investigator. She had her Medical Degree from the National University of Cordoba in 1991 and completed a specialty training in Internal Medicine in 1994. In 2003, she completed a fellowship in Diabetes and Obesity research from Favaloro University. She is co-leading our South America operation with Dr. Ghassan Tyra in Brazil and Dr. Leslie Coghlan in Chile.

Dr. Barwijuk leads our MPR phase I, inpatient unit in Warsaw Poland. He also leads projects in Central and Eastern Europe with other regional directors in the region. He trains and mentors research staff to secure superior quality delivery of clinical studies. He leads relationships with institutions and drug agencies. He represent the company with Sponsors in Europe.

Dr. Andrzej Barwijuk is a specialist in obstetrics and gynecology. He has graduated from the Medical University of Bialystok, Poland. In 1995-2006 was the lead of the gynecological department in the St. Family's Hospital in Warsaw. During his medical practice he gained many years’ experience as a Principal Investigator in all phases of clinical trials. He is a member of: The American Cosmetic Gynecology Society (FACOG, ISC), Foundation of the American Association of Gynecologic Laparoscopists (FAAGL), Polish Gynecological Society (PTG) and Polish Video Surgical Society (PTW).

Dr. Li co-leads projects with USA East Coast sponsors from Michigan and Boston based offices. Dr. Li leads development projects in China and co-lead MPR-Asia operation. Dr. Li consults on scientific matters on clinical studies design and implementation.

Dr. Li brings experience in industrial field application support, biomedical research experience in Protein Chemistry, Cell biology and Molecular biology. He is also an expert in computational analysis and interpretation utilizing bioinformatics tools. He has interacted with government, biotech and pharmaceutical companies at every level of government, industry and academia. Dr. Li completed major business deals with top research institutes and large pharmaceutical companies and has worked closely with research, development, and business groups to improve existing products and develop new ones. Dr. Li brings personal, business and academic ties to China and other Asian countries, which, in combination with his expertise in Drug Development helped the Company’s strategic plan to work on pre-clinical projects with Chinese companies. Dr. Li received his MD from Shanghai Medical University, China, and his PhD from the University of Cincinnati in Ohio.

Mr. Kuzmanovski manages quantitative tools and services for research projects developing necessary software or web based tools/GUI. Mr. Kuzmanovski also leads budgeting and financial planning for projects using computer based techniques. He co-leads a Company expertise center for Clinical Trials Risks management group.

Mr. Kuzmanovski brings experience in Operational Metrics, Controls, and Budgeting. He has been involved with Business Process Engineering, Internal Audit, Customer Care and Forecasting. Mr. Kuzmanovski specializes in the re-engineering, automation, and reporting of business processes. His skills also include data warehouse development and web based reporting (Brio and Business Objects). Over the past 7 years Mr. Kuzmanovski has held positions in Operations, Finance, Reporting, and Genetic Research. Mr. Kuzmanovski has a proven ability to adapt and contribute in any arena. He received a Masters of Business Administration from the William E. Simon School of Business with concentrations in Finance and Information Systems as well as a Bachelors of Science with Honors in Biochemistry from the University of Buffalo where he did genetic research.

Mr. Rich directs financial operations, plans projects budgeting including currency and operational risks management. Mr. Rich negotiates contracts with Sponsors and medical sites to assure completion of projects successfully. Mr. Rich co-leads South America operation with Dr. Coghlan and Dr. Steinacher.

Mr. Rich brings extensive experience in operations, budgeting, and financial planning at a top Fortune 500 Company where he held senior positions. His experiences include engineering, budgeting for large projects and large organizations, managing resources, customer service, quality control (ISO_9000 and 6 sigma processes), and typical line organizational metrics. Mr. Rich has completed an Executive Masters of Business Administration at Michigan State University. Prior to this position, Mr. Rich worked for Detroit Edison at a senior leadership position as Director. During his career at Edison he was a two-time recipient of highest award for outstanding achievement. Mr. Rich is an expert in lean operating principals. He is visionary and committed to value creation principles.

Mr. Rashed seeks business opportunities from Sponsors and leads business development projects from initiation to implementation. He reviews operational plans and budgets. Mr. Rashed directs Risk Sharing programs with leading Bio-Pharmaceutical companies. Mr. Rashed also co-leads the MPR-Asia operation with Dr. Kapoor, Dr. Li, and Dr. Jamil.

Mr. Rashed brings extensive experience in operations, financial and asset management working for top Fortune 500 companies. Mr. Rashed held executive leadership positions in the Drug Development Industry managing several aspects of the clinical research at global levels interfacing with Sponsors, Medical Centers, Labs, & Governmental Drug Agencies. During his career, Max assisted in managing of operations that had annual budgets that exceeded $8 billion. His experience background includes operations and logistics across the value stream map and leadership roles across a wide range of business activities. Max completed in 2000 an Executive Masters of Business Administration from Michigan State University.

Dr. Jamil directs CNS research projects with Sponsors. He consults on CNS studies’ design and implementation and leads scientific committees leveraging Key Opinion Leaders expertise in several CNS Sub-specialties. Dr. Jamil leads several health institutions partnerships in Michigan and North America. He co-leads Asia operation after leading the set up of several sites network in CNS and Diabetes research in India and Bangladesh.

Dr. Jamil brings academic and medical expertise to manage an established clinical research infrastructure. Dr. Jamil has many years of experience in medical education and administration gained in leadership roles at leading Medical centers in Michigan in addition to experience in the conduct of clinical trials. Dr. Jamil graduated with honors in Pharmacology from the Dhaka Medical College/Dhaka University in Bangladesh and after training with the Michigan State University Affiliated Psychiatric Hospitals Training Program, entered private practice. Dr. Jamil leads successful institutional initiatives in several Asia countries and in the Gulf expanding the scale and scope or research operations in Diabetes, ID, Oncology, Cardiology, CNS and other therapeutic areas.

Mr. Piticas leads staffing for CRO business in Europe. He leads also a patient call center, IT support solutions for regional and international projects. He seeks business projects from local and European sponsors and coordinate support and implementation with Dr. Barwijiuk

Mr. Piticas brings to the Company expertise in managing business in Central and Eastern Europe, a major region of MPR’s international business. He has over 15 years of domestic and international experience in business including investment management, recruitment services and human resources. He presently leads the company business operation for call centers, early phases research and is a member of the board of directors of Central & Eastern Europe Research Institute. Mr. Piticas is a dynamic entrepreneur with a track record of successful leadership. He has shown strong commitment to the Company as a major investor.